T1	Intervention 110 241	two theophylline (CAS 58-55-9) sustained release preparations (T: Bronchoretard Capsules/R: Capsule formulation from the US market)
T2	Intervention 476 627	Following individual dosing of 100-300 mg theophylline twice a day, a pharmacokinetic profile for 24 h was derived after seven days of multiple dosing.
T3	Intervention 628 825	All relevant parameters for rate (Cmax ss, Cmin ss, Cav ss, plateau time, peak-trough fluctuation, nocturnal excess, tmax ss) and extent of absorption (AUCss) were calculated for both formulations.
